Lincoln Pharmaceuticals is currently trading at Rs. 194.65, up by 4.90 points or 2.58% from its previous closing of Rs. 189.75 on the BSE.
The scrip opened at Rs. 190.90 and has touched a high and low of Rs. 200.65 and Rs. 187.60 respectively. So far 85582 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 256.20 on 29-Mar-2017 and a 52 week low of Rs. 148.00 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 200.65 and Rs. 176.15 respectively. The current market cap of the company is Rs. 392.40 crore.
The promoters holding in the company stood at 33.18%, while Institutions and Non-Institutions held 0.53% and 66.29% respectively.
Lincoln Pharmaceuticals has incorporated a wholly owned subsidiary (WOS) company by name ‘Savebux Finance & Investment’ in India, which is registered with the Registrar of companies, Gujarat at Ahmedabad on October 9, 2017.
Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets ,Capsules,Injectables,Syrups and Ointments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |